South State Corp Novartis Ag Transaction History

South State Corp

$1.45 Billion
Q3 2024

A detailed history of South State Corp transactions in Novartis Ag stock. As of the latest transaction made, South State Corp holds 10,395 shares of NVS stock, worth $1.02 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

10,395

Previous 10,796 3.71%

Holding current value

$1.02 Million

Previous $1.15 Million 4.0%

% of portfolio

0.08%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$106.13 - $120.89 $42,558 - $48,476	-401 Reduced 3.71%	10,395 $1.2 Million
Q2 2024 Aug 02, 2024	SELL	$92.57 - $107.37 $17,495 - $20,292	-189 Reduced 1.72%	10,796 $1.15 Million
Q1 2024 May 06, 2024	SELL	$95.27 - $108.47 $30,867 - $35,144	-324 Reduced 2.86%	10,985 $1.06 Million
Q4 2023 Feb 06, 2024	SELL	$92.27 - $101.54 $9,227 - $10,154	-100 Reduced 0.88%	11,309 $1.14 Million
Q3 2023 Nov 07, 2023	SELL	$94.73 - $105.13 $85,257 - $94,617	-900 Reduced 7.31%	11,409 $1.16 Million
Q2 2023 Aug 08, 2023	SELL	$92.52 - $104.91 $183,559 - $208,141	-1,984 Reduced 13.88%	12,309 $1.24 Million
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $35,773 - $41,486	-447 Reduced 3.03%	14,293 $1.31 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $56,435 - $69,112	-747 Reduced 4.82%	14,740 $1.34 Million
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $68,641 - $80,279	-920 Reduced 5.61%	15,487 $1.18 Million
Q2 2022 Aug 05, 2022	SELL	$80.52 - $93.75 $17,955 - $20,906	-223 Reduced 1.34%	16,407 $1.39 Million
Q1 2022 May 06, 2022	SELL	$80.11 - $90.62 $140,593 - $159,038	-1,755 Reduced 9.55%	16,630 $1.46 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $93,488 - $103,376	-1,173 Reduced 6.0%	18,385 $1.61 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $84,151 - $97,899	-1,029 Reduced 5.0%	19,558 $1.6 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $267,653 - $295,631	-3,140 Reduced 13.23%	20,587 $1.88 Million
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $470,940 - $555,370	-5,640 Reduced 19.21%	23,727 $2.03 Million
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $1.13 Million - $1.37 Million	-14,531 Reduced 33.1%	29,367 $2.77 Million
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $87,479 - $96,915	1,065 Added 2.49%	43,898 $3.82 Million
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $221,586 - $249,431	2,738 Added 6.83%	42,833 $3.74 Million
Q1 2020 May 04, 2020	BUY	$70.67 - $99.01 $529,530 - $741,881	7,493 Added 22.98%	40,095 $3.31 Million
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $63,937 - $72,290	758 Added 2.38%	32,602 $3.09 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $40,717 - $44,867	-476 Reduced 1.47%	31,844 $2.77 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $28,727 - $35,356	-381 Reduced 1.17%	32,320 $2.95 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $23,725 - $27,137	-315 Reduced 0.95%	32,701 $3.14 Million
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $2.31 Million - $2.58 Million	-31,410 Reduced 48.75%	33,016 $2.83 Million
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $54,823 - $63,415	-819 Reduced 1.26%	64,426 $5.55 Million
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $81,981 - $92,653	-1,263 Reduced 1.9%	65,245 $4.93 Million
Q1 2018 May 11, 2018	BUY	$70.39 - $84.15 $383,484 - $458,449	5,448 Added 8.92%	66,508 $5.38 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $1.12 Million - $1.2 Million	15,502 Added 34.03%	61,060 $5.13 Million
Q3 2017 Nov 09, 2017	SELL	$74.14 - $77.27 $70,803 - $73,792	-955 Reduced 2.05%	45,558 $3.91 Million
Q2 2017 Aug 10, 2017	BUY	N/A	46,513	46,513 $3.88 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account